Patent ID: 9175058
Filing Date: 2015-11-03
Classification: A61K,A61P,C07K

Abstract:
1. A method of immunotherapy in an individual comprising orally administering to the individual a therapeutically effective amount of a SIRS polypeptide comprising the N-terminal amino acid sequence (SEQ ID NO:5): X1-X2-X3-X3-X4-X4-X4-X4-X4-X4-Pro-X5-X2-X2-X6-X4-X4-X7-X7-X3-X4 wherein X1 is Met, Val, Leu or Cys; X2 is Thr, Ala or Gly; X3 is Glu, Arg, Asp or Lys; X4 is Gln, Ser, Asn or Gly; X5 is Glu, Arg, Asp or Lys; X6 is Ile, Leu, Val, Met or Thr, and; X7 is Ala, Cys, Thr or Gly, and wherein said polypeptide is not SIRS-a7, SIRS-a6 or SIRS-a5.